These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7054357)

  • 1. Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes.
    Pfaffenbach G; Lamm ME; Gigli I
    J Exp Med; 1982 Jan; 155(1):231-47. PubMed ID: 7054357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.
    Zhang W; Lachmann PJ
    Immunology; 1994 Jan; 81(1):137-41. PubMed ID: 8132210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in experimental IgA nephropathy: an antigen-mediated process.
    Rifai A; Chen A; Imai H
    Kidney Int; 1987 Dec; 32(6):838-44. PubMed ID: 3430967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of rat complement by soluble and insoluble rat IgA immune complexes.
    Rits M; Hiemstra PS; Bazin H; Van Es LA; Vaerman JP; Daha MR
    Eur J Immunol; 1988 Dec; 18(12):1873-80. PubMed ID: 3220102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
    Miletic VD; Hester CG; Frank MM
    J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of the immune complex-complement interaction by protein H of the alternative complement pathway and the natural inhibitor heparin.
    Spycher MO; Nydegger UE
    Eur J Immunol; 1984 Mar; 14(3):276-9. PubMed ID: 6231187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of complement activation by human IgA immune complexes.
    Imai H; Chen A; Wyatt RJ; Rifai A
    Clin Exp Immunol; 1988 Sep; 73(3):479-83. PubMed ID: 3061690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability of IgA to inhibit complement consumption by complement-fixing antigens and antigen-antibody complexes.
    Russell-Jones GJ; Ey PL; Reynolds BL
    Aust J Exp Biol Med Sci; 1984 Feb; 62 ( Pt 1)():1-10. PubMed ID: 6743139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y; Tamura N; Fujita T
    J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial activation of rat complement through the alternative pathway by rat insoluble IgA-immune complexes.
    Rits M; Bazin H; Vaerman JP
    Adv Exp Med Biol; 1987; 216B():1311-5. PubMed ID: 3425431
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.
    Chen A; Ding SL; Sheu LF; Song YB; Shieh SD; Shaio MF; Chou WY; Ho YS
    Lab Invest; 1994 May; 70(5):639-47. PubMed ID: 8196360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization of IgA immune precipitates by complement.
    Miller GW
    J Immunol; 1976 Oct; 117(4):1374-7. PubMed ID: 977953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation.
    Stewart WW; Johnson A; Steward MW; Whaley K; Kerr MA
    Mol Immunol; 1988 Dec; 25(12):1355-61. PubMed ID: 3266294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-idiotype antibody directly interferes with glomerular IgA immune complex deposition.
    Chen A; Sheu LF; Shaio MF; Huang TH; Ding SL; Lee WH
    Nephron; 1998; 78(4):464-73. PubMed ID: 9578073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
    Antón LC; Alcolea JM; Sánchez-Corral P; Marqués G; Sánchez A; Vivanco F
    Biochem J; 1989 Feb; 257(3):831-8. PubMed ID: 2784671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the alternative pathway of complement by immune complexes and degradation of these complexes by macrophages.
    Daha MR
    Ann Immunol (Paris); 1982; 133C(2):245-52. PubMed ID: 7114798
    [No Abstract]   [Full Text] [Related]  

  • 19. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Gadd KJ; Reid KB
    Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubilization of immune precipitates by six isolated alternative pathway proteins.
    Fujita T; Takata Y; Tamura N
    J Exp Med; 1981 Dec; 154(6):1743-51. PubMed ID: 6459396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.